Sinoway Industrial Co., Ltd.

Tulathromycin A 217500-96-4 Tulathromycin A 217500-96-4

Tulathromycin A 217500-96-4
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

1. Basic information of Tulathromycin A 217500-96-4:

Product name

Tulathromycin A

CAS No.:

217500-96-4

Appearance

White powder

MF:

C41H79 N3 O12

Grade

Enterprise standard

Assay

95% up

Bacterial endotoxin

< 2EU

Heavy metal

< 20 ppm

Certificate

Vet-GMP

Packing size

1kg/tin, 10tin/drum



2. Usage of Tulathromycin 217500-96-4 :


Tulathromycin is a novel macrolide antibiotic used exclusively for mammals. Tulathromycin has rapid absorption, high bioavailability, long half-life and long lasting effect. A single parenteral administration can provide a full range of treatments and has broad prospects for veterinary clinical applications.
The pharmacokinetic characteristics of Tulathromycin are rapidly absorbed at the injection site after single-dose administration, the effective blood concentration is maintained for a long time, the elimination is slow, the apparent distribution volume is large, the bioavailability is high, and the peripheral tissue concentration is higher. Plasma concentration. Extensive tissue distribution and good cell penetration are important features of Tulathromycin metabolism. Accumulation in immune cells is also an important feature of Tulathromycin. The drug concentration of lung tissue is always higher than the plasma concentration, and the drug accumulates in alveolar macrophages and neutrophils, and then slowly releases from these cells. The accumulation of Tulathromycin in the lungs was evident during the pre-dose phase.

3. COA of Tulathromycin 217500-96-4:


COA of Tulathromycin 217500-96-4

  • Dexamethasone 50-02-2
    Basic information:Product Name: DexamethasoneMolecular Formula : C22H29FO5Molecular Weight: 392.46CAS No.: 50-02-2Appearance: White crystalline powderSpecifications:USP38/BP2010/EP6Usages :It used for aut... Dexamethasone 50-02-2
  • Ketoconazole 65277-42-1
    Basic information of KetoconazoleNameKetoconazoleAlias fungoral; Onofin K; nizoral; ketoderm; fungarest;1-[4-(4[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phe... Ketoconazole 65277-42-1
  • Alogliptin Benzoate 850649-62-6
    Basic information of Alogliptin benzoate:NameAlogliptin benzoateCAS NO.850649-62-6Molecular FormulaC18H21N5O2.C7H6O2Molecular Weight461.519Grade StandardMedicine grade / 99% min / PMDA / DMFPackage S... Alogliptin Benzoate 850649-62-6
  • Atracurium Besylate 64228-81-5
    Basic information of Atracurium besylate:NameAtracurium besylateAliasCAS NO.64228-81-5 Molecular FormulaC65H82N2O18S2Molecular Weight1243.48Quality StandardCurrent USPPackage Size2kg or 3kg/tin/carton... Atracurium Besylate 64228-81-5

MORE_DETAIL Tulathromycin A 217500-96-4

1. Basic information of Tulathromycin A 217500-96-4:

Product name

Tulathromycin A

CAS No.:

217500-96-4

Appearance

White powder

MF:

C41H79 N3 O12

Grade

Enterprise standard

Assay

95% up

Bacterial endotoxin

< 2EU

Heavy metal

< 20 ppm

Certificate

Vet-GMP

Packing size

1kg/tin, 10tin/drum



2. Usage of Tulathromycin 217500-96-4 :


Tulathromycin is a novel macrolide antibiotic used exclusively for mammals. Tulathromycin has rapid absorption, high bioavailability, long half-life and long lasting effect. A single parenteral administration can provide a full range of treatments and has broad prospects for veterinary clinical applications.
The pharmacokinetic characteristics of Tulathromycin are rapidly absorbed at the injection site after single-dose administration, the effective blood concentration is maintained for a long time, the elimination is slow, the apparent distribution volume is large, the bioavailability is high, and the peripheral tissue concentration is higher. Plasma concentration. Extensive tissue distribution and good cell penetration are important features of Tulathromycin metabolism. Accumulation in immune cells is also an important feature of Tulathromycin. The drug concentration of lung tissue is always higher than the plasma concentration, and the drug accumulates in alveolar macrophages and neutrophils, and then slowly releases from these cells. The accumulation of Tulathromycin in the lungs was evident during the pre-dose phase.

3. COA of Tulathromycin 217500-96-4:


COA of Tulathromycin 217500-96-4
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//